Increased levels of nuclear WRAP53 protein have been detected in head and neck squamous cell carcinoma [11], ovarian epithelial cancer [12], rectal adenocarcinoma [13], esophageal squamous cell carcinoma [14], as well as in breast cancer [15]. Here, WRAP53 is linked to breast carcinoma.